TF2

The ASCO article - $PDSB shows BTD efficacy in colorectal mets resistant to current immunotherapy : ascopubs.org/doi/full/10.12…

News: NCI's Quadruple immunotherapy for colorectal cancer in (QuICC) trial for mismatch repair-proficient metastatic colorectal cancer" 2/26 publication - did much worse than $PDSB PDS01ADC + Pembro = SYNERGY $MRK pubmed.ncbi.nlm.nih.gov/41520164/

Tecentriq+PDS01ADC is being studied by NCI. Mayo just showed Tecentriq boosts Chemo in St 3 Colon Ca - short leap to adding $PDSB Rx to the cocktail "The combination of PDS01ADC, atezolizumab, is under investigation to improve outcomes in difficult-to-treat cancers" -N.C.I.

@Oligo_bio @WexCapital @DesertDweller93 He couldn't hit a bull in the ass with an oar - "Woh is me the fake PDSB long/short!)

@WexCapital @DesertDweller93 People like @DesertDweller93 are insufferable, acting like a vulture. It's so obvious he's pretending to care about HD while he's just in it for his own $. And a few years ago he was shilling $PDSB (he blocked me, I dont even remember when but probably due to some $PDSB comments)

Rick's Cafe is an After hours club.

$PDSB BTD:

"...and for the rest of your life."

Like England and the USA, pembro and 2 $PDSB drugs - Versamune and PDS01ADC- share a "Special Relationship" yielding best in class status in HPV+ HNSCC and mismatch Colon Ca Mets.

.@nyjets trade up ahead of @Nygiants for Jordan Tyson.

#ESPN took 10 sec to demonstrate the 3 @arvxll ncaa sacks. @Giants

.@arvxll is the new Bo Callahan

"LOVE LOVE LOVE. LOVE IS ALL YOU NEED @@GiantsViews HAH HA HA! @Giants

.@nyjets "WON'T YOU COME HOME BILL (DAVID) BAILEY-WON'T YOU COME HOME?"

@arvxll IS Vernon Gholston - @nyjets pick Bailey! "What have you done for me lately?"

Stops being harvested at $PDSB -huge volume on no news - BTD or an offering coming?

"WolfPack also questioned $POET 's subsequent actions, including efforts to address the Passive Foreign Inv Co. issue and plans to redomicile. “These are not the actions of a company that believes the issue is inconsequential,” stocktwits.com/news-articles/…

Mismatch mColonCa- Opdivo + Yervoy "Standard of care" - "The ORR was higher with nivolumab/ipilimumab (71%) than with nivolumab alone (58%)." targetedonc.com/view/nivolumab… Combining PDS01ADC with HAIP FUDR achieved a 77.8% 6-month ORR -curetoday.com/view/pds01adc-… $BMY $MRK $PDSB